About Barbara Schilberg
Form D filings for ENB Therapeutics from 2018 to 2023 list Barbara Schilberg as director.
Barbara Schilberg first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Barbara Schilberg in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Barbara Schilberg works with at each company, as listed on that company's latest Form D.
ENB Therapeutics, Inc. · Form D, Oct 3, 2023
SJ
Sumayah Jamal
Executive officer and director
SH
Stuart Hwang
Director
WO
Walter Olesiak
Director
AS
Albert Sokol
Secretary